FDA Approved: ALOSETRON HYDROCHLORIDE — Supplemental Application (Eywa Pharma Inc)

View source ↗

Summary

FDA approves Eywa Pharma Inc's supplemental application for alosetron hydrochloride (ANDA211621).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome

Drugs mentioned

• Alosetron hydrochloride (Alosetron hydrochloride)

Snippet

SUPPL AP for ALOSETRON HYDROCHLORIDE (ALOSETRON HYDROCHLORIDE)